Practical medical applications of quantitative MR relaxometry

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 4, 2012, Pages 805-824

  Margaret Cheng, Hai Ling ^a,b   Stikov, Nikola ^c   Ghugre, Nilesh R ^d   Wright, Graham A ^b,d,e  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Sunnybrook Health Sciences Centre   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

iron overload; multiple sclerosis; myocardial infarction; relaxation; T1 relaxation; T2; T2 relaxation

Indexed keywords

METHEMOGLOBIN;

ACCURACY; ACUTE HEART INFARCTION; BIOPSY; BLEEDING; BRAIN; BRAIN ISCHEMIA; BRAIN TUMOR; COMPUTER; COMPUTER PROGRAM; EDEMA; EPILEPSY; HEART INFARCTION SIZE; HISTOLOGY; HUMAN; INFLAMMATION; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE RELAXOMETRY; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOARTHRITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL PROCESSING; VASODILATATION;

HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING;

EID: 84866426598     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23718     Document Type: Review

References (143)

1. Bloembergen N, Purcell EM, Pound RV,. Relaxation effects in nuclear magnetic resonance absorbtion. Phys Rev 1948; 73: 679.
2. Koenig SH, Brown RD III, Gibson JF, Ward RJ, Peters TJ,. Relaxometry of ferritin solutions and the influence of the Fe3+ core ions. Magn Reson Med 1986; 3: 755-767.
3. Deoni S,. Magnetic resonance relaxation and quantitative measurements in the brain. Methods Mol Biol 2011; 711: 65-108.
4. Erkinjuntti T, Ketonen L, Sulkava R, Sipponen J, Vuorialho M, Iivanainen M,. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease? J Neurol Neurosurg Psychiatry 1987; 50: 37-42. (Pubitemid 17218354)
5. Baudrexel S, Nurnberger L, Rub U, et al. Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson's disease. Neuroimage 2010; 51: 512-520.
6. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005; 23: 1-25. (Pubitemid 40269946)
7. Tofts P, editor. Quantitative MRI of the brain: measuring changes caused by disease. Chichester, West Sussex: Wiley; 2005.
8. Miller DH, Grossman RI, Reingold SC, McFarland HF,. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998; 121: 3-24. (Pubitemid 28045503)
9. McDonald WI, Miller DH, Thompson AJ,. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. Ann Neurol 1994; 36: 14-18. (Pubitemid 24205818)
10. Vrenken H, Geurts JJ, Knol DL, et al. Whole-brain T1 mapping in multiple sclerosis: global changes of normal-appearing gray and white matter. Radiology 2006; 240: 811-820. (Pubitemid 44267339)
11. Manfredonia F, Ciccarelli O, Khaleeli Z, Tozer DJ, Sastre-Garriga J, Miller DH, Thompson AJ,. Normal-appearing brain t1 relaxation time predicts disability in early primary progressive multiple sclerosis. Arch Neurol 2007; 64: 411-415. (Pubitemid 46425697)
12. Papadopoulos K, Tozer DJ, Fisniku L, et al. T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis. Mult Scler 2010; 16: 427-433.
13. Bitsch A, Kuhlmann T, Stadelmann C, Lassmann H, Lucchinetti C, Bruck W,. A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions. Ann Neurol 2001; 49: 793-796. (Pubitemid 32530247)
14. van Walderveen MA, Kamphorst W, Scheltens P, et al. Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology 1998; 50: 1282-1288. (Pubitemid 28240340)
15. Brix G, Schad LR, Deimling M, Lorenz WJ,. Fast and precise T1 imaging using a TOMROP sequence. Magn Reson Imaging 1990; 8: 351-356. (Pubitemid 20321947)
16. Tardif CL, Collins DL, Eskildsen SF, Richardson JB, Pike GB,. Segmentation of cortical MS lesions on MRI using automated laminar profile shape analysis. Med Image Comput Comput Assist Interv 2010; 13 (Pt 3): 181-188.
17. Zellini F, Niepel G, Tench CR, Constantinescu CS,. Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis. Mult Scler 2009; 15: 1442-1449.
18. MacKay A, Whittall K, Adler J, Li D, Paty D, Graeb D,. In vivo visualization of myelin water in brain by magnetic resonance. Magn Reson Med 1994; 31: 673-677. (Pubitemid 24166822)
19. Laule C, Leung E, Lis DK, et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler 2006; 12: 747-753. (Pubitemid 46111766)
20. MacKay AL, Vavasour IM, Rauscher A, et al. MR relaxation in multiple sclerosis. Neuroimaging Clin N Am 2009; 19: 1-26.
21. Ropele S, Langkammer C, Enzinger C, Fuchs S, Fazekas F,. Relaxation time mapping in multiple sclerosis. Expert Rev Neurother 2011; 11: 441-450.
22. Englund E, Brun A, Gyorffy-Wagner Z, Larsson E, Persson B,. Relaxation times in relation to grade of malignancy and tissue necrosis in astrocytic gliomas. Magn Reson Imaging 1986; 4: 425-429. (Pubitemid 17208149)
23. Kurki T, Komu M,. Spin-lattice relaxation and magnetization transfer in intracranial tumors in vivo: effects of Gd-DTPA on relaxation parameters. Magn Reson Imaging 1995; 13: 379-385.
24. Just M, Thelen M,. Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. Radiology 1988; 169: 779-785.
25. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232. (Pubitemid 29463104)
26. Sourbron S, Ingrisch M, Siefert A, Reiser M, Herrmann K,. Quantification of cerebral blood flow, cerebral blood volume, and blood-brain-barrier leakage with DCE-MRI. Magn Reson Med 2009; 62: 205-217.
27. Runge VM, Muroff LR, Wells JW,. Principles of contrast enhancement in the evaluation of brain diseases: an overview. J Magn Reson Imaging 1997; 7: 5-13. (Pubitemid 28365633)
28. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41-51.
29. Roberts HC, Roberts TP, Brasch RC, Dillon WP,. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000; 21: 891-899. (Pubitemid 30262836)
30. DeWitt LD, Kistler JP, Miller DC, Richardson EP Jr, Buonanno FS,. NMR-neuropathologic correlation in stroke. Stroke 1987; 18: 342-351. (Pubitemid 17059658)
31. Bernarding J, Braun J, Hohmann J, et al. Histogram-based characterization of healthy and ischemic brain tissues using multiparametric MR imaging including apparent diffusion coefficient maps and relaxometry. Magn Reson Med 2000; 43: 52-61. (Pubitemid 30027112)
32. Lansberg MG, Thijs VN, O'Brien MW, et al. Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. AJNR Am J Neuroradiol 2001; 22: 637-644. (Pubitemid 32318688)
33. Larsson HB, Hansen AE, Berg HK, Rostrup E, Haraldseth O,. Dynamic contrast-enhanced quantitative perfusion measurement of the brain using T1-weighted MRI at 3T. J Magn Reson Imaging 2008; 27: 754-762. (Pubitemid 351508089)
34. Conlon P, Trimble MR, Rogers D, Callicott C,. Magnetic resonance imaging in epilepsy: a controlled study. Epilepsy Res 1988; 2: 37-43. (Pubitemid 18008552)
35. Rugg-Gunn FJ, Boulby PA, Symms MR, Barker GJ, Duncan JS,. Whole-brain T2 mapping demonstrates occult abnormalities in focal epilepsy. Neurology 2005; 64: 318-325.
36. Townsend TN, Bernasconi N, Pike GB, Bernasconi A,. Quantitative analysis of temporal lobe white matter T2 relaxation time in temporal lobe epilepsy. Neuroimage 2004; 23: 318-324. (Pubitemid 39119462)
37. Baxendale SA, van Paesschen W, Thompson PJ, et al. The relationship between quantitative MRI and neuropsychological functioning in temporal lobe epilepsy. Epilepsia 1998; 39: 158-166. (Pubitemid 28074351)
38. Van Paesschen W, Sisodiya S, Connelly A, et al. Quantitative hippocampal MRI and intractable temporal lobe epilepsy. Neurology 1995; 45: 2233-2240. (Pubitemid 27100254)
39. Bernasconi A, Bernasconi N, Caramanos Z, et al. T2 relaxometry can lateralize mesial temporal lobe epilepsy in patients with normal MRI. Neuroimage 2000; 12: 739-746.
40. Kaltwasser JP, Gottschalk R, Schalk KP, Hartl W,. Non-invasive quantitation of liver iron-overload by magnetic resonance imaging. Br J Haematol 1990; 74: 360-363. (Pubitemid 20106066)
41. St Pierre TG, Clark PR, Chua-anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood 2005; 105: 855-861. (Pubitemid 40070775)
42. Wood JC, Enriquez C, Ghugre N, et al. Physiology and pathophysiology of iron cardiomyopathy in thalassemia. Ann N Y Acad Sci 2005; 1054: 386-395. (Pubitemid 43031046)
43. Papakonstantinou O, Alexopoulou E, Economopoulos N, et al. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major. J Magn Reson Imaging 2009; 29: 853-859.
44. Schwenzer NF, Machann J, Haap MM, et al. T2* relaxometry in liver, pancreas, and spleen in a healthy cohort of one hundred twenty-nine subjects-correlation with age, gender, and serum ferritin. Invest Radiol 2008; 43: 854-860.
45. Schein A, Enriquez C, Coates TD, Wood JC,. Magnetic resonance detection of kidney iron deposition in sickle cell disease: a marker of chronic hemolysis. J Magn Reson Imaging 2008; 28: 698-704.
46. Berdoukas V, Chouliaras G, Moraitis P, Zannikos K, Berdoussi E, Ladis V,. The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study. J Cardiovasc Magn Reson 2009; 11: 20.
47. Recht MP, Resnick D,. Magnetic resonance imaging of articular cartilage: an overview. Top Magn Reson Imaging 1998; 9: 328-336. (Pubitemid 29031113)
48. Link TM, Stahl R, Woertler K,. Cartilage imaging: motivation, techniques, current and future significance. Eur Radiol 2007; 17: 1135-1146. (Pubitemid 46691942)
49. Blumenkrantz G, Majumdar S,. Quantitative magnetic resonance imaging of articular cartilage in osteoarthritis. Eur Cell Mater 2007; 13: 76-86.
50. Williams A, Gillis A, McKenzie C, et al. Glycosaminoglycan distribution in cartilage as determined by delayed gadolinium-enhanced MRI of cartilage (dGEMRIC): potential clinical applications. AJR Am J Roentgenol 2004; 182: 167-172. (Pubitemid 38017737)
51. Eckstein F, Burstein D, Link TM,. Quantitative MRI of cartilage and bone: degenerative changes in osteoarthritis. NMR Biomed 2006; 19: 822-854. (Pubitemid 44811544)
52. Kight AC, Dardzinski BJ, Laor T, Graham TB,. Magnetic resonance imaging evaluation of the effects of juvenile rheumatoid arthritis on distal femoral weight-bearing cartilage. Arthritis Rheum 2004; 50: 901-905. (Pubitemid 38326191)
53. Cheng HL, Islam SS, Loai Y, Antoon R, Beaumont M, Farhat WA,. Quantitative magnetic resonance imaging assessment of matrix development in cell-seeded natural urinary bladder smooth muscle tissue-engineered constructs. Tissue Eng Part C Methods 2010; 16: 643-651.
54. Stikov N, Keenan KE, Pauly JM, Smith RL, Dougherty RF, Gold GE,. Cross-relaxation imaging of human articular cartilage. Magn Reson Med 2011; 66: 725-734.
55. Potter HG, Chong le R, Sneag DB,. Magnetic resonance imaging of cartilage repair. Sports Med Arthrosc 2008; 16: 236-245.
56. Chai JW, Lin YC, Chen JH, et al. In vivo magnetic resonance (MR) study of fatty liver: importance of intracellular ultrastructural alteration for MR tissue parameters change. J Magn Reson Imaging 2001; 14: 35-41.
57. de Miguel MH, Yeung HN, Goyal M, et al. Evaluation of quantitative magnetic resonance imaging as a noninvasive technique for measuring renal scarring in a rabbit model of antiglomerular basement membrane disease. J Am Soc Nephrol 1994; 4: 1861-1868. (Pubitemid 24976990)
58. Johnson K, Davis PJ, Foster JK, McDonagh JE, Ryder CA, Southwood TR,. Imaging of muscle disorders in children. Pediatr Radiol 2006; 36: 1005-1018. (Pubitemid 44377852)
59. Maillard SM, Jones R, Owens C, et al. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis. Rheumatology (Oxford) 2004; 43: 603-608. (Pubitemid 38628191)
60. Workie DW, Graham TB, Laor T, et al. Quantitative MR characterization of disease activity in the knee in children with juvenile idiopathic arthritis: a longitudinal pilot study. Pediatr Radiol 2007; 37: 535-543. (Pubitemid 46767443)
61. Verstraete KL, Lang P,. Bone and soft tissue tumors: the role of contrast agents for MR imaging. Eur J Radiol 2000; 34: 229-246. (Pubitemid 30601696)
62. Gambarota G, Veltien A, van Laarhoven H, et al. Measurements of T1 and T2 relaxation times of colon cancer metastases in rat liver at 7 T. Magma 2004; 17: 281-287. (Pubitemid 40362311)
63. Cieszanowski A, Szeszkowski W, Golebiowski M, Bielecki DK, Grodzicki M, Pruszynski B,. Discrimination of benign from malignant hepatic lesions based on their T2-relaxation times calculated from moderately T2-weighted turbo SE sequence. Eur Radiol 2002; 12: 2273-2279. (Pubitemid 36940323)
64. Rieke V, Butts Pauly K,. MR thermometry. J Magn Reson Imaging 2008; 27: 376-390. (Pubitemid 351214044)
65. Winter JD, Estrada M, Cheng HL,. Normal tissue quantitative T1 and T2* MRI relaxation time responses to hypercapnic and hyperoxic gases. Acad Radiol 2011; 18: 1159-1167.
66. Rhee TK, Larson AC, Prasad PV, et al. Feasibility of blood oxygenation level-dependent MR imaging to monitor hepatic transcatheter arterial embolization in rabbits. J Vasc Interv Radiol 2005; 16: 1523-1528. (Pubitemid 43017699)
67. Dyke JP, Panicek DM, Healey JH, et al. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 2003; 228: 271-278. (Pubitemid 36736103)
68. Krasin MJ, Xiong X, Reddick WE, et al. A model for quantitative changes in the magnetic resonance parameters of muscle in children after therapeutic irradiation. Magn Reson Imaging 2006; 24: 1319-1324. (Pubitemid 44827581)
69. Andersson T, Ericsson A, Eriksson B, et al. Relative proton density and relaxation times in liver metastases during interferon treatment. Br J Radiol 1989; 62: 433-437.
70. Stoffner R, Schullian P, Widmann G, Bale R, Kremser C,. [Magnetic resonance imaging of radiofrequency current-induced coagulation zones in the ex vivo bovine liver]. Rofo 2010; 182: 690-697.
71. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179. (Pubitemid 33139463)
72. Carpenter JP, He T, Kirk P, Roughton M, et al. On T2* magnetic resonance and cardiac iron. Circulation 2011; 123: 1519-1528.
73. Ghugre NR, Enriquez CM, Gonzalez I, Nelson MD Jr, Coates TD, Wood JC,. MRI detects myocardial iron in the human heart. Magn Reson Med 2006; 56: 681-686. (Pubitemid 44338890)
74. Wood JC, Otto-Duessel M, Gonzalez I, et al. Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. Transl Res 2006; 148: 272-280. (Pubitemid 44634299)
75. Wood JC, Aguilar M, Otto-Duessel M, Nick H, Nelson MD, Moats R,. Influence of iron chelation on R1 and R2 calibration curves in gerbil liver and heart. Magn Reson Med 2008; 60: 82-89. (Pubitemid 351956612)
76. Van de Werf F, Bax J, Betriu A, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-2945.
77. Bradley WG Jr,. MR appearance of hemorrhage in the brain. Radiology 1993; 189: 15-26. (Pubitemid 23292911)
78. Friedrich MG, Abdel-Aty H, Taylor A, Schulz-Menger J, Messroghli D, Dietz R,. The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol 2008; 51: 1581-1587. (Pubitemid 351508364)
79. Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV, Simonetti OP,. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009; 11: 56.
80. Ghugre NR, Ramanan V, Pop M, et al. Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI. Magn Reson Med 2011; 66: 1129-1141.
81. Ganame J, Messalli G, Dymarkowski S, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J 2009; 30: 1440-1449.
82. Garcia-Dorado D, Theroux P, Solares J, et al. Determinants of hemorrhagic infarcts. Histologic observations from experiments involving coronary occlusion, coronary reperfusion, and reocclusion. Am J Pathol 1990; 137: 301-311. (Pubitemid 20232992)
83. Lotan CS, Miller SK, Bouchard A, et al. Detection of intramyocardial hemorrhage using high-field proton (1H) nuclear magnetic resonance imaging. Cathet Cardiovasc Diagn 1990; 20: 205-211. (Pubitemid 20246653)
84. Leung G, Moody AR,. MR imaging depicts oxidative stress induced by methemoglobin. Radiology 2010; 257: 470-476.
85. Foltz WD, Yang Y, Graham JJ, Detsky JS, Wright GA, Dick AJ,. MRI relaxation fluctuations in acute reperfused hemorrhagic infarction. Magn Reson Med 2006; 56: 1311-1319. (Pubitemid 44865313)
86. Uren NG, Crake T, Lefroy DC, de Silva R, Davies GJ, Maseri A,. Reduced coronary vasodilator function in infarcted and normal myocardium after myocardial infarction. N Engl J Med 1994; 331: 222-227. (Pubitemid 24226679)
87. Wacker CM, Bock M, Hartlep AW, et al. Changes in myocardial oxygenation and perfusion under pharmacological stress with dipyridamole: assessment using T*2 and T1 measurements. Magn Reson Med 1999; 41: 686-695. (Pubitemid 29205714)
88. Foltz WD, Huang H, Fort S, Wright GA,. Vasodilator response assessment in porcine myocardium with magnetic resonance relaxometry. Circulation 2002; 106: 2714-2719. (Pubitemid 35364927)
89. Ghugre NR, Ramanan V, Pop M, et al. Myocardial BOLD imaging at 3 T using quantitative T2: application in a myocardial infarct model. Magn Reson Med 2011; 66: 1739-1747.
90. Yan AT, Shayne AJ, Brown KA, et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006; 114: 32-39. (Pubitemid 44305272)
91. Schmidt A, Azevedo CF, Cheng A, et al. Infarct tissue heterogeneity by magnetic resonance imaging identifies enhanced cardiac arrhythmia susceptibility in patients with left ventricular dysfunction. Circulation 2007; 115: 2006-2014. (Pubitemid 46625951)
92. Messroghli DR, Greiser A, Frohlich M, Dietz R, Schulz-Menger J,. Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging 2007; 26: 1081-1086. (Pubitemid 47548170)
93. Detsky JS, Paul G, Dick AJ, Wright GA,. Reproducible classification of infarct heterogeneity using fuzzy clustering on multicontrast delayed enhancement magnetic resonance images. IEEE Trans Med Imaging 2009; 28: 1606-1614.
94. Jackowski C, Christe A, Sonnenschein M, Aghayev E, Thali MJ,. Postmortem unenhanced magnetic resonance imaging of myocardial infarction in correlation to histological infarction age characterization. Eur Heart J 2006; 27: 2459-2467. (Pubitemid 44522153)
95. Waller C, Kahler E, Hiller KH, et al. Myocardial perfusion and intracapillary blood volume in rats at rest and with coronary dilatation: MR imaging in vivo with use of a spin-labeling technique. Radiology 2000; 215: 189-197. (Pubitemid 30190529)
96. Vignaux O, Dhote R, Duboc D, et al. Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis: a 1-year follow-up study. Chest 2002; 122: 1895-1901. (Pubitemid 36051121)
97. Abdel-Aty H, Simonetti O, Friedrich MG,. T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging 2007; 26: 452-459. (Pubitemid 350194566)
98. Aherne T, Yee ES, Tscholakoff D, Gollin G, Higgins C, Ebert PA,. Diagnosis of acute and chronic cardiac rejection by magnetic resonance imaging: a non-invasive in-vivo study. J Cardiovasc Surg (Torino) 1988; 29: 587-590.
99. Conrad CH, Brooks WW, Hayes JA, Sen S, Robinson KG, Bing OH,. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995; 91: 161-170.
100. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA,. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011; 57: 891-903.
101. Barral JK, Gudmundson E, Stikov N, Etezadi-Amoli M, Stoica P, Nishimura DG,. A robust methodology for in vivo T1 mapping. Magn Reson Med 2011; 64: 1057-1067.
102. Zhu DC, Penn RD,. Full-brain T1 mapping through inversion recovery fast spin echo imaging with time-efficient slice ordering. Magn Reson Med 2005; 54: 725-731. (Pubitemid 41233770)
103. Gowland PA, Leach MO,. A simple method for the restoration of signal polarity in multi-image inversion recovery sequences for measuring T1. Magn Reson Med 1991; 18: 224-231.
104. Look DC, Locker DR,. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970; 41: 250-251.
105. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP,. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004; 52: 141-146. (Pubitemid 39295266)
106. Slavin GS, Gupta SN,. Efficient T1 mapping of the heart using an interleaved look-locker acquisition with saturation recovery. In: Proceeding of the Annual Meeting of SCMR, Rome, Italy, February 2-4, 2007. (abstract 324).
107. Deoni SC, Rutt BK, Peters TM,. Rapid combined T1 and T2 mapping using gradient recalled acquisition in the steady state. Magn Reson Med 2003; 49: 515-526. (Pubitemid 36262820)
108. Cheng HL, Wright GA,. Rapid high-resolution T(1) mapping by variable flip angles: accurate and precise measurements in the presence of radiofrequency field inhomogeneity. Magn Reson Med 2006; 55: 566-574. (Pubitemid 43352555)
109. Kershaw LE, Cheng HL,. A general dual-bolus approach for quantitative DCE-MRI. Magn Reson Imaging 2011; 29: 160-166.
110. Winter JD, Akens MK, Cheng HL,. Quantitative MRI assessment of VX2 tumour oxygenation changes in response to hyperoxia and hypercapnia. Phys Med Biol 2011; 56: 1225-1242.
111. Winter JD, St Lawrence KS, Cheng HL. Quantification of renal perfusion: Comparison of arterial spin labeling and dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2011 Jul 14. doi: 10.1002/jmri.22660. [Epub ahead of print] PMID: 21761490
112. Whittall KP, MacKay AL, Graeb DA, Nugent RA, Li DK, Paty DW,. In vivo measurement of T2 distributions and water contents in normal human brain. Magn Reson Med 1997; 37: 34-43. (Pubitemid 27008828)
113. Sussman MS, Vidarsson L, Pauly JM, Cheng HL,. A technique for rapid single-echo spin-echo T2 mapping. Magn Reson Med 2010; 64: 536-545.
114. Deoni SC, Ward HA, Peters TM, Rutt BK,. Rapid T2 estimation with phase-cycled variable nutation steady-state free precession. Magn Reson Med 2004; 52: 435-439. (Pubitemid 39025292)
115. Brittain JH, Hu BS, Wright GA, Meyer CH, Macovski A, Nishimura DG,. Coronary angiography with magnetization-prepared T2 contrast. Magn Reson Med 1995; 33: 689-696.
116. Zia M, Ghugre N, Paul G, Stainsby J, et al. Characterizing myocardial edema and hemorrhage using T2, T2*, and diastolic wall thickness post acute myocardial infarction. Journal of Cardiovascular Magnetic Resonance 2010; 12 (Suppl 1): P179.
117. Hennig J,. Multiecho imaging sequences with low refocusing flip angles. J Magn Reson 1988; 78: 397-407.
118. Lebel RM, Wilman AH,. Transverse relaxometry with stimulated echo compensation. Magn Reson Med; 64: 1005-1014.
119. Prasloski T, Madler B, Xiang QS, Mackay A, Jones C,. Applications of stimulated echo correction to multicomponent T(2) analysis. Magn Reson Med 2011 doi:101002/mrm23157 2011 [Epub ahead of print].
120. Kingsley PB, Ogg RJ, Reddick WE, Steen RG,. Correction of errors caused by imperfect inversion pulses in MR imaging measurement of T1 relaxation times. Magn Reson Imaging 1998; 16: 1049-1055. (Pubitemid 29189662)
121. Rakow-Penner R, Daniel B, Yu H, Sawyer-Glover A, Glover GH,. Relaxation times of breast tissue at 1.5T and 3T measured using IDEAL. J Magn Reson Imaging 2006; 23: 87-91. (Pubitemid 43100723)
122. Gochberg DF, Gore JC,. Quantitative magnetization transfer imaging via selective inversion recovery with short repetition times. Magn Reson Med 2007; 57: 437-441. (Pubitemid 46214549)
123. Beaumont M, Odame I, Babyn PS, Vidarsson L, Kirby-Allen M, Cheng HL,. Accurate liver T2 measurement of iron overload: a simulations investigation and in vivo study. J Magn Reson Imaging 2009; 30: 313-320.
124. Ghugre NR, Enriquez CM, Coates TD, Nelson MD Jr, Wood JC,. Improved R2* measurements in myocardial iron overload. J Magn Reson Imaging 2006; 23: 9-16. (Pubitemid 43100712)
125. Reiter D, Roque R, Lin P, et al. Mapping proteoglycan-bound water in cartilage: improved specificity of matrix assessment using multiexponential transverse relaxation analysis. Magn Reson Med 2011; 65: 377-384.
126. Ghugre NR, Coates TD, Nelson MD, Wood JC,. Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens. Magn Reson Med 2005; 54: 1185-1193. (Pubitemid 41567198)
127. Noseworthy MD, Kim JK, Stainsby JA, Stanisz GJ, Wright GA,. Tracking oxygen effects on MR signal in blood and skeletal muscle during hyperoxia exposure. J Magn Reson Imaging 1999; 9: 814-820. (Pubitemid 29266394)
128. Zimmerman J, Britten W,. Nuclear magnetic resonance studies in multiple phase systems: lifetimes of a water molecule in an absorbing phase silica gel. J Phys Chem 1957; 61 (1328).
129. Deoni SC, Rutt BK, Arun T, Pierpaoli C, Jones DK,. Gleaning multicomponent T1 and T2 information from steady-state imaging data. Magn Reson Med 2008; 60: 1372-1387.
130. Tozer DJ, Davies GR, Altmann DR, Miller DH, Tofts PS,. Correlation of apparent myelin measures obtained in multiple sclerosis patients and controls from magnetization transfer and multicompartmental T2 analysis. Magn Reson Med 2005; 53: 1415-1422. (Pubitemid 40734663)
131. Vavasour IM, Whittall KP, MacKay AL, Li DK, Vorobeychik G, Paty DW,. A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients. Magn Reson Med 1998; 40: 763-768. (Pubitemid 28493656)
132. Laule C, Vavasour IM, Moore GR, et al. Water content and myelin water fraction in multiple sclerosis. A T2 relaxation study. J Neurol 2004; 251: 284-293. (Pubitemid 38387145)
133. Wu Y, Alexander AL, Fleming JO, Duncan ID, Field AS,. Myelin water fraction in human cervical spinal cord in vivo. J Comput Assist Tomogr 2006; 30: 304-306. (Pubitemid 43739316)
134. Oh J, Han ET, Pelletier D, Nelson SJ,. Measurement of in vivo multi-component T2 relaxation times for brain tissue using multi-slice T2 prep at 1.5 and 3 T. Magn Reson Imaging 2006; 24: 33-43. (Pubitemid 43061201)
135. Levesque I, Sled JG, Narayanan S, et al. The role of edema and demyelination in chronic T1 black holes: a quantitative magnetization transfer study. J Magn Reson Imaging 2005; 21: 103-110.
136. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 2005; 106: 1460-1465. (Pubitemid 41129616)
137. Argyropoulou MI, Kiortsis DN, Astrakas L, Metafratzi Z, Chalissos N, Efremidis SC,. Liver, bone marrow, pancreas and pituitary gland iron overload in young and adult thalassemic patients: a T2 relaxometry study. Eur Radiol 2007; 17: 3025-3030. (Pubitemid 350142326)
138. Cheng HL, Holowka S, Moineddin R, Odame I,. Liver iron overload assessment by T2* magnetic resonance imaging in pediatric patients: an accuracy and reproducibility study. Am J Hematol 2012;87:435-437.
139. Kornreich L, Horev G, Yaniv I, Stein J, Grunebaum M, Zaizov R,. Iron overload following bone marrow transplantation in children: MR findings. Pediatr Radiol 1997; 27: 869-872. (Pubitemid 27494164)
140. Ghugre NR, Wood JC,. Relaxivity-iron calibration in hepatic iron overload: probing underlying biophysical mechanisms using a Monte Carlo model. Magn Reson Med 2011; 65: 837-847.
141. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB,. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 56: 786-794. (Pubitemid 8235183)
142. Yellon DM, Hausenloy DJ,. Myocardial reperfusion injury. N Engl J Med 2007; 357: 1121-1135.
143. Dharmakumar R, Arumana JM, Tang R, Harris K, Zhang Z, Li D,. Assessment of regional myocardial oxygenation changes in the presence of coronary artery stenosis with balanced SSFP imaging at 3.0 T: theory and experimental evaluation in canines. J Magn Reson Imaging 2008; 27: 1037-1045. (Pubitemid 351614614)